2. What is DCT?
• DCTs are the trials where Patients/Subjects cater remotely and data
captured using technological advanced equipments.
• Protocol and other CSDs are designed in a way that all trial activities
can be performed at Patient’s Home or at a Remote Location.
• Subjects have to visit the site at rare occasions only
• Hybrid Trials are good solutions for complex projects
4. Technology which we use
• Cloud Computing (To Store, communicate and integrate the data)
• AI & ML (To Do Analytical Part, To generate data through Stats)
• MS Office 365 (To record important information on real time)
• Tablet and Wearable Trackers (To Capture the Vital and real time info.)
• eCRFs (Small Office Team need to manage the important parts)
• Tab to eCRF Integration (Need to do for Most of the Subject Level Records.
It serves as a Source and directly integrated to eCRF)
• SAE Monitoring through Virtual PI Calls (Helpline Number for any
immediate Assistance and Data Capture)
• IVRS/IWRS Reminders for Visits to be conducted, IP Management
5. How we can contribute from India in DCT
• By Creating Analytical tools, we may be very helpful in updating the
CL Team on real time basis
• Central Monitors can learn few techniques and need to train the
Phlebo, Nurse and Pharmacists about masking the data and any other
legal implications (If Any) based on Country regulations. They can
review and evaluate most of the trial data remotely.
• We can also manage the SAE Documentation and Subject Helpline
activities remotely from India
• We can customize our role for DCT as per the requirements like
Access providers, training providers, QC reviewer and many.
6. DCT as a Whole - Conclusion
• The concept which will change the healthcare industry from scratch
• Data what we produce will have a great weightage to manage the complicated
health issues
• The Data can be able to work on AI ML Bot trainings and to train the new Doctors
• Patient History data will be available in just one touch to any Physician for better
treatment and evaluations of underlying disease
• Insurance sector will also open up where we can be able to pitch in and get a
good remuneration by analyzing the Subject Data
• Clinical trials will be within the reach to all communities and populations
• Stats will become more judgmental and clearer
• Many other Sectors will open up like Disease spread evaluations in regions,
Weather impact on health to the region, How to overcome a Disease spread
(Planning & Strategic thinking) and so on and so forth.
7. Thanks.
You can reach me for more info.
Preyas Parikh
Clinical Research Professional
+91-9725956241